(Q44880525)

English

Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing p

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing p (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Bolwig TG

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Husum H

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sánchez C

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Mathé AA

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Hansen SL

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

204-215

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Modification of seizure activity by electrical stimulation. II. Motor seizure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Conditioning and sensitisation in the longitudinal course of affective illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Recurrence in affective disorder. I. Case register study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Patterns of sensitisation in the course of affective illness. A life-charting study of treatment-refractory depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Efficacy of levetiracetam: a review of three pivotal clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Levetiracetam for acute mania

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Effect of the New Antiepileptic Drug Levetiracetam in an Animal Model of Mania

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Endogenous control of hippocampal epileptogenesis: a molecular cascade involving brain-derived neurotrophic factor and neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Stimulation of neuropeptide Y gene expression by brain-derived neurotrophic factor requires both the phospholipase Cgamma and Shc binding sites on its receptor, TrkB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Regulation of Neuropeptides in Adult Rat Forebrain by the Neurotrophins BDNF and NGF

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Dynamic changes of brain-derived neurotrophic factor protein levels in the rat forebrain after single and recurring kindling-induced seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Distribution of pancreatic polypeptide receptors in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Y-receptor subtypes--how many more?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

A receptor subtype involved in neuropeptide-Y-induced food intake

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Suppressed epileptogenesis in BDNF mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Brain-derived neurotrophic factor delays hippocampal kindling in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Neuronal activity and brain-derived neurotrophic factor regulate the density of inhibitory synapses in organotypic slice cultures of postnatal hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: temporal evolution of changes as compared to neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Extracellular levels of neuropeptide Y are markedly increased in the dorsal hippocampus of freely moving rats during kainic acid-induced seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Role of the Y5 neuropeptide Y receptor in limbic seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Depression: a new animal model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Sodium valproate reduces immobility in the behavioral 'despair' test in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Behavioural despair in rats: A new model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

The place of anticonvulsant therapy in bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded "depressed", Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.12.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YEBEH.2003.12.004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44880525&oldid=1518282722"